Related content

Growth hormone response in low-dose apomorphine test correlates with nigrostriatal dopamine transporter binding in patients with Parkinson’s disease

By Happe S.   Tings T.   Koch W.   Welsch J.   Helmschmied K.   Baier P. C.   Meller J.   Wuttke W.   Paulus W.   Tatsch K.   Trenkwalder C.  

Journal of Neural Transmission, Vol. 114, Iss. 5, 2007-05 ,pp. : 589-594

Springer Publishing Company

Access to resources Recommend Favorite

Study of the prevalence of Parkinson's disease using dopamine transporter imaging

By Kim Jong-Min   Kim Ji Seon   Kim Ki Woong   Lee Seok Bum   Park Joon Hyuk   Lee Jung Jae   Kim Yu Kyeong   Kim Sang Eun   Jeon Beom S.  

Neurological Research, Vol. 32, Iss. 8, 2010-10 ,pp. : 845-851

Maney Publishing

Access to resources Recommend Favorite

Cerebral amyloid PET imaging in Alzheimer’s disease

By Jack Clifford   Barrio Jorge   Kepe Vladimir  

Acta Neuropathologica, Vol. 126, Iss. 5, 2013-11 ,pp. : 643-657

Springer Publishing Company

Access to resources Recommend Favorite

Striatal Dopamine Transporter Availability in Drug-Naive Patients With Schizophrenia: A Case-Control SPECT Study With [ 99m Tc]-TRODAT-1 and a Meta-Analysis

By Chen Kao Chin   Yang Yen Kuang   Howes Oliver   Lee I Hui   Landau Sabine   Yeh Tzung Lieh   Chiu Nan Tsing   Chen Po See   Lu Ru Band   David Anthony S.   Bramon Elvira  

Schizophrenia Bulletin, Vol. 39, Iss. 2, 2013-03 ,pp. : 378-386

Oxford University Press

Access to resources Recommend Favorite

Progressive striatal and cortical dopamine receptor dysfunction in Huntington’s disease: a PET study

By Piccini P.  

Brain, Vol. 126, Iss. 5, 2003-05 ,pp. : 1127-1135

Oxford University Press

Access to resources Recommend Favorite